Carenostics is a company dedicated to changing the way chronic diseases are treated through innovation, clinical accuracy, and clinical partnerships.

Bharat Rao

Carenostics

Carenostics develops healthcare AI solutions to identify opportunities for earlier clinical intervention with chronic disease patients. We learn machine learning models from patient data collected in routine care, and integrate directly into provider EHRs to help physicians identify patients with undiagnosed chronic disease, project their decline over time, and match them to guideline / evidence-based treatment. Carenostics partners with leading providers, payers, pharma companies, care management companies, academics, and government agencies to address the gaps in chronic disease care. Our flagship solution, CKDx, is a clinical decision support tool developed with the goal of eradicating undiagnosed chronic kidney disease while reducing the disparities in care faced by minority populations.

Metric
Company Name	Carenostics
Symbol
MSH ID	COM:CARENOSTICS
Market	PRIVATE
Sector	Healthcare
Industry	Healthcare Technology
Country	US
Stage	Seed
Employee Count	13
Website	carenostics.com
LinkedIn	carenostics
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	82
Web Traffic Growth	-0.82
Valuation
Raised Capital	5M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:CARENOSTICS

Carenostics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue